Potential Coverage of a Multivalent M Protein-Based Group a Streptococcal Vaccine

Vaccine - Netherlands
doi 10.1016/j.vaccine.2013.01.019
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Protective Study With a Group a Streptococcal M Protein Vaccine. INFECTIVITY CHALLENGE OF HUMAN VOLUNTEERS

Journal of Clinical Investigation
Medicine
1973English

Group a Streptococcal Emm Type Prevalence Among Symptomatic Children in Cape Town and Potential Vaccine Coverage

Pediatric Infectious Disease Journal
Child HealthInfectious DiseasesPediatricsPerinatologyMicrobiology
2014English

Domains of Group a Streptococcal M Protein That Confer Resistance to Phagocytosis, Opsonization and Protection: Implications for Vaccine Development

Molecular Microbiology
MicrobiologyMolecular Biology
2006English

Group a Streptococcal Pharyngotonsillitis

Biomedical Journal of Scientific & Technical Research
2018English

Immunization With a Streptococcal Multiple-Epitope Recombinant Protein Protects Mice Against Invasive Group a Streptococcal Infection

PLoS ONE
Multidisciplinary
2017English

Kindergarten-Based Outbreak of Perianal Group a Streptococcal Infection

Archives of Disease in Childhood
Child HealthPediatricsPerinatology
2003English

Potential Mechanisms for Treatment Failures in Group a Streptococcal Pharyngitis † 838

Pediatric Research
Child HealthPediatricsPerinatology
1998English

Correlates of Protection for M Protein-Based Vaccines Against Group a Streptococcus

Journal of Immunology Research
MedicineAllergyImmunology
2015English

Vaccine Coverage in PLWH: Disparities and Potential Impact of Vaccine Hesitancy

Human Vaccines and Immunotherapeutics
MedicineAllergyImmunologyPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy